* U.S. FDA grants fast track designation for the development
of Oragenics’ AG013 for oral mucositis
The post BRIEF-Oragenics says U.S. FDA grants fast track designation for development of co’s AG013 for oral mucositis appeared first on NASDAQ.
BRIEF-Oragenics says U.S. FDA grants fast track designation for development of co’s AG013 for oral mucositis
